CPT1B and breast carcinoma: Wang et al8 have reported in breast cancer that the JAK/STAT3 signaling can facilitate the transcription of CPT1B, thereby promoting FAO and sustaining the proliferation of breast cancer stem cells as well as their chemoresistance.